Join the movement
Read the manifestoHow can we help?
Contact supportSee the spike.
Shift the behavior.
Save the cost.
Signos integrates hundreds of millions of data points with each user’s profile to deliver real-time, personalized guidance, driving better outcomes than many medications at a fraction of the cost and without side effects. Paired with Stelo by Dexcom and Signos’ AI, the platform shows how food, activity, stress, and sleep affect the body in the moment, then empowers small, sustainable changes that last.
High cost of obesity
73.6%
Of U.S. adults over 20 are overweight or obese1
$1,861
More per obese employee per year in medical costs2
$173B
In obesity-related costs to the U.S. healthcare system3
The Solution
Signos makes deployment, measurement, and scale simple:
- Real-Time Data & ROI Tracking: Monitor adoption, adherence, and outcomes instantly without guesswork or waste.
- Precision Health: Truly personalized feedback ensures changes stick, moving away from one-size-fits-all approaches.
- Scalable & Complementary: Works alongside GLP-1s or other programs, from healthy to non-insulin-dependent type II users, with no prescription required.
- High Engagement: Users check the app an average of 7 times per day in the first month meaning real results at lower costs.
- Turnkey Deployment: No integrations needed; rollout in weeks with streamlined contracting.
The Results
- 85% of members report losing weight in the first 30 days4
- Members report losing on average 7.75% of their starting weight (compared to 4.1% with a GLP-1) in 6 months.4
Review
“The power of Signos is in helping people make real changes in their life and the appeal of the pain-free technology is undeniable. You cannot begin to take control of your health until you understand how the choices you make are impacting your body. It’s all in the data.”
– Kurstin Bartholomew
How It Works:
Flexible Outreach: Signos handles as much or as little member communication as preferred.
Best-in-Class Tools: Users receive top-tier CGMs and access to the first FDA-cleared glucose management system for healthy weight.
Actionable Guidance: Real-time glucose insights translate into simple steps that encourage smarter eating, movement, and lifestyle choices for habits that stick.
Transparent Data: In-the-moment results flow into a dashboard, giving you visibility into impact you can measure in weeks, not months.
Seamless Implementation
PUPM Promise: Straightforward per-user, per-month pricing with no hidden fees for streamlined contracting.
Built for Trust: FDA-cleared, HIPAA-compliant, with aggregate reporting for population insights.
Tech Ready: Integrates with Apple Health, Google Health Connect, and all major wearables for seamless data flow.
Customizable Nutrition: Optional 1:1 coaching that complements your existing health plan.
Easy Onboarding: Launch in as little as two weeks and scale at your pace with real-time support every step of the way.
Start a conversation
Don't miss out!
Sign up to be the first to know about special offers and exciting Signos news.
Signos indications: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.
The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.